Oruka Stock Surges Nearly 700% Amid Insider Sale of $687K Worth of Shares
Arjun Agarwal, Senior Vice President and Finance Officer at Oruka Therapeutics (ORKA), sold approximately $687,000 worth of shares in June 2026. The insider transaction involved the exercise of options followed by an immediate sale, reducing his direct equity stake significantly.
Tickers: $ORKA
Topics: executive ownership SEC Form 4 stock sale